Zobrazeno 1 - 10
of 93
pro vyhledávání: '"H Petra Kok"'
Autor:
Daan R. Löke, H. Petra Kok, Roxan F. C. P. A Helderman, Bella Bokan, Nicolaas A. P. Franken, Arlene L. Oei, Jurriaan B. Tuynman, Pieter J. Tanis, Johannes Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 40, Iss 1 (2023)
AbstractIntroduction Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) aims to treat microscopic disease left after CytoReductive Surgery (CRS). Thermal enhancement depends on the temperatures achieved. Since the location of microscopic disease is un
Externí odkaz:
https://doaj.org/article/82b13eeeab604bdaaa4d2a2d094dad54
Autor:
Akke Bakker, Remko Zweije, H. Petra Kok, Lukas J. A. Stalpers, G. Henrike Westerveld, Karel A. Hinnen, Geertjan van Tienhoven, M. Willemijn Kolff, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 1408-1414 (2022)
Objective The in-house developed 70 MHz AMC-4 locoregional hyperthermia system has been in clinical use since 1984. This device was recently commercialized as the Alba 4D (Medlogix®, Rome, Italy), with a similar geometrical 4-waveguide design. At th
Externí odkaz:
https://doaj.org/article/73ea93929dad46a2a642a3e68544d0bd
Autor:
H. Petra Kok, Johannes Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 39, Iss 1, Pp 265-277 (2022)
Background Hyperthermia treatment planning is increasingly used in clinical applications and recommended in quality assurance guidelines. Assistance in phase-amplitude steering during treatment requires dedicated software for on-line visualization of
Externí odkaz:
https://doaj.org/article/10ae34cea01447f68cfe72a5b8fb660b
Autor:
Roxan F. C. P. A. Helderman, Bella Bokan, Gregor G. W. van Bochove, Hans M. Rodermond, Elsy Thijssen, Wouter Marchal, Arezo Torang, Daan R. Löke, Nicolaas A. P. Franken, H. Petra Kok, Pieter J. Tanis, Johannes Crezee, Arlene L. Oei
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionIn patients with limited peritoneal metastasis (PM) originating from colorectal cancer, cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a potentially curative treatment option. This combined tr
Externí odkaz:
https://doaj.org/article/d035d5b08b89485c9c0226c89d4560a8
Autor:
Daan R. Löke, H. Petra Kok, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Jurriaan B. Tuynman, Remko Zweije, Jan Sijbrands, Pieter J. Tanis, Johannes Crezee
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionCytoReductive Surgery (CRS) followed by Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) is an often used strategy in treating patients diagnosed with peritoneal metastasis (PM) originating from various origins such as gastric, colorecta
Externí odkaz:
https://doaj.org/article/077ef8fcb12f4e8392aaf6f13e6b5182
Autor:
Margarethus M. Paulides, Dario B. Rodrigues, Gennaro G. Bellizzi, Kemal Sumser, Sergio Curto, Esra Neufeld, Hazael Montanaro, H. Petra Kok, Hana Dobsicek Trefna
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 1425-1442 (2021)
Background The success of cancer hyperthermia (HT) treatments is strongly dependent on the temperatures achieved in the tumor and healthy tissues as it correlates with treatment efficacy and safety, respectively. Hyperthermia treatment planning (HTP)
Externí odkaz:
https://doaj.org/article/2cce2b38698242f78223e26327e4d225
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 229-240 (2021)
Purpose In pancreatic cancer treatment, hyperthermia can be added to increase efficacy of chemo- and/or radiotherapy. Gas in stomach, intestines and colon is often in close proximity to the target volume. We investigated the impact of variations in g
Externí odkaz:
https://doaj.org/article/7118227da80d4baf8af8bc98597c317d
Autor:
Daan R. Löke, Roxan F. C. P. A. Helderman, Hans M. Rodermond, Pieter J. Tanis, Geert J. Streekstra, Nicolaas A. P. Franken, Arlene L. Oei, Johannes Crezee, H. Petra Kok
Publikováno v:
International Journal of Hyperthermia, Vol 38, Iss 1, Pp 38-54 (2021)
Background Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after cytoreductive surgery (CRS). During HIPEC, fluid (41–43 °C) is administered and drained through a limited number of catheters,
Externí odkaz:
https://doaj.org/article/9bad3523b2e647ac8b0e7cf89a722b30
Autor:
Daan R. Löke, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Pieter J. Tanis, Johannes Crezee, H. Petra Kok
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 145-161 (2021)
Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy
Externí odkaz:
https://doaj.org/article/a2b892d19472473faa89e3eb2261f7a1
Autor:
H. Petra Kok, Marcus Beck, Daan R. Löke, Roxan F. C. P. A. Helderman, Geertjan van Tienhoven, Pirus Ghadjar, Peter Wust, Hans Crezee
Publikováno v:
International Journal of Hyperthermia, Vol 37, Iss 1, Pp 76-88 (2020)
Introduction Intravenous chemotherapy plus abdominal locoregional hyperthermia is explored as a noninvasive alternative to hyperthermic intraperitoneal chemotherapy (HIPEC) in treatment of peritoneal carcinomatosis (PC). First clinical results demons
Externí odkaz:
https://doaj.org/article/d51c9120152f4cc3a173afdbf35a6f38